Skip to Main Content
Text logo saying "Invest in Hamilton" in bold with a red maple leaf symbol.

Invest in Hamilton
Close-up of a microscope used in life sciences research and biotechnology innovation
Investment

Hamilton Life Sciences Companies Receive Ontario Funding to Advance Health Innovation

Four Hamilton-connected life sciences companies — Esphera SynBio, NodeAI, Stoked Bio, and Synmedix — are receiving support through Ontario’s Life Sciences Innovation Fund to commercialize health technologies, AI diagnostics and next-generation therapeutics.

May 11, 2026
An aerial view of SucroCan's sugar refinery located at the Port of Hamilton in Hamilton, Ontario, Canada
Announcement Investment

Port of Hamilton Welcomes New SucroCan Sugar Refinery

Sucro Can Canada has opened a $135-million sugar refinery at the Port of Hamilton, adding major processing capacity and supporting supply chains across Ontario’s food manufacturing sector. The facility strengthens Canada’s agri-food industry and domestic refining capacity.

May 8, 2026
Aerial view of an industrial port with docked ships, storage tanks, cranes, and a surrounding cityscape under a partly cloudy sky.
Investment

Hamilton becomes new inland gateway for global trade with rail container approval

Hamilton has taken a major step forward as a national logistics hub. New CBSA approval unlocks inland rail container capacity at the Port of Hamilton, enabling more efficient trade routes, reducing highway congestion, and strengthening Southern Ontario’s supply chains.

Apr 2, 2026

  • Topic

  • Date

  • Type

  • Location

  • Industry

Close-up of a microscope used in life sciences research and biotechnology innovation
Investment

Hamilton Life Sciences Companies Receive Ontario Funding to Advance Health Innovation

Four Hamilton-connected life sciences companies — Esphera SynBio, NodeAI, Stoked Bio, and Synmedix — are receiving support through Ontario’s Life Sciences Innovation Fund to commercialize health technologies, AI diagnostics and next-generation therapeutics.

May 11, 2026
Industrial building with a glass entrance and logos for OmniaBio and CCRM on the facade. Parking area in the foreground.
Investment

Feds and OmniaBio partner to expand Hamilton facility for revolutionary cell and gene therapies

The Government of Canada announced a collaboration with OmniaBio to expand its facility at McMaster Innovation Park. This expansion will focus on manufacturing cell and gene therapies, providing production services globally, and strengthening Canada's role in global value chains. The project aims to revolutionize treatments for chronic diseases such as cancer, autoimmune conditions, diabetes, cardiovascular, and neurological diseases.

Apr 3, 2025
Industrial building with a glass entrance and logos for OmniaBio and CCRM on the facade. Parking area in the foreground.
Investment

OmniaBio launches Canada’s largest cell and gene therapy manufacturing facility

New facility to drive biotech innovation with advanced AI and robotics, creating jobs and boosting local economy

Oct 17, 2024
The historical facade of McMaster University surrounded by trees with a blue sky backdrop
Investment

McMaster-led study to revolutionize cancer care backed by $4.9M Pfizer investment

McMaster University leads groundbreaking study to transform multiple myeloma treatment

Jul 10, 2024
A scientist in a mask and lab coat explains the chemical engineering process at Fusion
Investment

AstraZeneca’s $2.4B acquisition of Fusion Pharmaceuticals marks milestone in cancer treatment

McMaster University spin-out acquired by pharmaceutical giant for $2.4 billion

Mar 27, 2024